Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 164

Работа: Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)

  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Статья2017Цитирований: 6
    ABI
  2. Regulatory mechanisms of PD-1/PD-L1 in cancers

    Xin Lin, Kuan Kang, Pan Chen +5

    Статья2024Цитирований: 5
    ABI
  3. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Статья2017Цитирований: 5
    ABI
  4. Innate and adaptive immune cells in the tumor microenvironment

    Thomas F. Gajewski, Hans Schreiber, Yang‐Xin Fu

    Обзорная статья2013Цитирований: 3
    ABI
  5. A human gut microbial gene catalogue established by metagenomic sequencing

    Junjie Qin, Ruiqiang Li, Jeroen Raes +50

    Статья2010Цитирований: 3
    ABI
  6. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

    Статья2015Цитирований: 3
    ABI
  7. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    Vyara Matson, Jessica Fessler, Riyue Bao +5

    Статья2018Цитирований: 3
    ABI
  8. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

    Статья2020Цитирований: 3
    ABI
  9. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Статья2021Цитирований: 3
    ABI
  10. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

    Takeshi Tanoue, Satoru Morita, Damian R. Plichta +25

    Статья2019Цитирований: 2
    ABI
  11. Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant

    Zachariah DeFilipp, Patricia P. Bloom, Mariam Torres Soto +7

    Статья2019Цитирований: 2
    ABI
  12. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

    S Deleu, Kathleen Machiels, Jeroen Raes +2

    Обзорная статья2021Цитирований: 2
    ABI
  13. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

    Ara Koh, Filipe De Vadder, Petia Kovatcheva‐Datchary +1

    Обзорная статья2016Цитирований: 2
    ABI
  14. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

    William R. Wikoff, Andrew Anfora, Jun Liu +4

    Статья2009Цитирований: 2
    ABI
  15. Microbiota: a key orchestrator of cancer therapy

    Soumen Roy, Giorgio Trinchieri

    Обзорная статья2017Цитирований: 2
    ABI
  16. Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer

    Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska +26

    Статья2017Цитирований: 2
    ABI
  17. Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer

    Pasquale Marino, Mariangela Mininni, Giovanni Deiana +7

    Статья2024Цитирований: 2
    ABI
  18. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment

    Jiachun Lian, Yanfang Liang, Hailiang Zhang +5

    Обзорная статья2022Цитирований: 2
    ABI
  19. Nanoparticle biointerfacing by platelet membrane cloaking

    Che‐Ming Jack Hu, Ronnie H. Fang, Kuei-Chun Wang +19

    Статья2015Цитирований: 2
    ABI
  20. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation

    Marta Wlodarska, Chengwei Luo, Raivo Kolde +19

    Статья2017Цитирований: 2
    ABI